US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.94

-0.5800-1.90%

Post-market: 29.81-0.1216-0.41%19:30 EDT

Volume:5K

Turnover:145.87K

Market Cap:31.43M

PE:- -

High:30.40

Open:30.40

Low:29.81

Close:30.52

52wk High:33.59

52wk Low:23.00

Shares:1.05M

Float Shares:1.05M

Volume Ratio:0.18

T/O Rate:0.46%

Dividend:0.07

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call

THOMSON REUTERS

Gartner Inc. Stock Outperforms Competitors on Strong Trading Day

Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says

Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says

THOMSON REUTERS

Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says

THOMSON REUTERS

Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Benzinga Earnings

Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth

Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss

MT Newswires Live

Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million

Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI

THOMSON REUTERS

Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers

THOMSON REUTERS

Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth

Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate

Benzinga Earnings

Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33

THOMSON REUTERS

Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million

Hims & Hers Health Q2 EPS USD -0.37

THOMSON REUTERS

Hims & Hers Health, Inc. Q3 REV View $793.1 Mln

THOMSON REUTERS

Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/HEAL/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HEAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","market":"US","secType":"STK","nameCN":"Global X HealthTech ETF","latestPrice":29.935,"timestamp":1787601600000,"preClose":30.515,"halted":0,"volume":4849,"hourTrading":{"tag":"盘后","latestPrice":29.8134,"preClose":29.935,"latestTime":"19:30 EDT","volume":16,"amount":478.96,"timestamp":1787614206764,"change":-0.1216,"changeRate":-0.004062,"amplitude":0},"delay":0,"changeRate":-0.019007045715222083,"floatShares":1049843,"shares":1049843,"eps":0,"marketStatus":"Closed","change":-0.58,"latestTime":"08-24 16:00:00 EDT","open":30.4,"high":30.4,"low":29.8134,"amount":145865.077124,"amplitude":0.019223,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":30.515,"sharesOutstanding":1329868,"nav":30.41,"aum":31926607.75,"dividendRate":0.002415,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.8134,"preClose":29.935,"latestTime":"19:30 EDT","volume":16,"amount":478.96,"timestamp":1787614206764,"change":-0.1216,"changeRate":-0.004062,"amplitude":0},"volumeRatio":0.179974,"impliedVol":0.0888,"impliedVolPercentile":0.376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","floatShares":1049843,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.179974,"shares":1049843,"dividePrice":0.0723,"high":30.4,"amplitude":0.019223,"preClose":30.515,"low":29.8134,"week52Low":23,"pbRate":"--","week52High":33.59,"institutionHeld":0,"latestPrice":29.935,"eps":0,"divideRate":0.002415,"volume":4849,"delay":0,"ttmEps":0,"open":30.4,"prevYearClose":29.215,"prevWeekClose":30.515,"prevMonthClose":26.9077,"prevQuarterClose":27.59,"fiveDayClose":28.88,"twentyDayClose":26.44,"sixtyDayClose":25.015},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HEAL\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HEAL","amount":0.071843,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"HEAL","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-06-27","symbol":"HEAL","amount":0.00815,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HEAL\",market:\"US\",,,undefined,":[{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00815,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.071843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HEAL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HEAL\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658448952","title":"Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2658448952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658448952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:19","pubTimestamp":1786396790,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471SF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","HMYY","HIMS","HIYY","BK4196","THNR","GLAM","HIMZ","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658895282","title":"Gartner Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2658895282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658895282?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:17","pubTimestamp":1786396620,"startTime":"0","endTime":"0","summary":"DJ Gartner Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gartner Inc.  rose 4.08% to $193.17 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.06% to 7,753.11 and Dow Jones Industrial Average  falling 0.11% to 53,975.98.This was the stock's second consecutive day of gains.Gartner Inc. closed 27.34% short of its 52-week high of $265.85, which the company reached on September 26th.The stock outperformed some of its competitors Monday, as Trade Desk Inc. Cl A  fell 2.97% to $13.39, IQVIA Holdings Inc.  rose 1.38% to $241.99, and Omnicom Group Inc.  fell 0.69% to $84.65.Trading volume  eclipsed its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU2362541513.USD","BK4613","LU0130518102.USD","LU0321505439.SGD","IE00BFXG1179.USD","LU0321505868.SGD","LU2517655291.USD","LU1481011671.HKD","TTDU","LU2362541273.HKD","LU0154245756.USD","LU2362540622.SGD","LU2357305700.SGD","LU0648000940.SGD","OMC","LU0154245673.USD","LU0198837287.USD","BK4585","IT","BK4588","LU0130103400.USD","LU1599440770.SGD","LU1720051017.SGD","LU1509826696.USD","LU0528227936.USD","LU0882574055.USD","LU0130102774.USD","LU0348723411.USD","LU1201861249.SGD","LU0731783048.USD","LU1548497426.USD","IQV","BK4023","EKG","LU1989764748.USD","TTD","BK4530","LU1481011911.USD","LU0742537680.HKD","BK4528","LU0130517989.USD","LU0477156797.USD","LU0107464264.USD","HEAL","LU2517655028.SGD","LU1261432733.SGD","RSPC","LU1720051108.HKD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954258","title":"Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954258","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954258?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:08","pubTimestamp":1786396110,"startTime":"0","endTime":"0","summary":"Hims & Hers able to scale peptide offering if US law allows, CFO saysNEW YORK, Aug 10 (Reuters)-Hims & Hers Health CFO Yemi Okupe said on Monday the telehealth company could rapidly sell peptide products at scale, if U.S. regulation allows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","GLAM","HIYY","HIMS","HIMY","HIMZ","HMYY","BK4196","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658095467","title":"Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658095467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658095467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:00","pubTimestamp":1786395648,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc. reports results for the quarter ended June 30 - Earnings SummaryHims & Hers Health, Inc.HIMS.Nreported a quarterly adjusted loss of 37 cents per share for the quarter ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4471Z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","THNR","HIMY","HIMS","BK4196","HMYY","HEAL","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954585","title":"Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954585?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","HEAL","BK4196","HIMY","HIMZ","THNR","HIMS","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951208","title":"Hims & Hers Health Confident it Can Rapidly Scale Peptide Offering if Current Regulation Allows, CFO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951208?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:41","pubTimestamp":1786394467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471UT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HEAL","HMYY","HIMY","THNR","BK4196","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658519329","title":"Hims & Hers Health Boosts Revenue Target, Swings to 2Q Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658519329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658519329?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:31","pubTimestamp":1786393860,"startTime":"0","endTime":"0","summary":"Hims & Hers Health raised its revenue projections for the year, though higher costs swung it to a loss in the second quarter.The telehealth platform said it now projects $3.1 billion to $3.3 billion i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658285959","title":"Hims & Hers Shares Drop After Mixed Q2 Earnings — Details","url":"https://stock-news.laohu8.com/highlight/detail?id=2658285959","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658285959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:17","pubTimestamp":1786393043,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers posted Q2 results - here are the details you need to know.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61092738/hims-hers-shares-drop-after-mixed-q2-earnings-details","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959179","title":"Telehealth Platform Hims & Hers Swings to Q2 Net Loss as Margin Pressure Offsets Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959179","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959179?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:15","pubTimestamp":1786392909,"startTime":"0","endTime":"0","summary":"Telehealth platform Hims & Hers swings to Q2 net loss as margin pressure offsets revenue growthOverviewUS health platform's Q2 revenue rose 38% yr/yr, beating analyst expectationsCompany posted Q2 net","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","GLAM","HIMZ","HIMS","HEAL","BK4196","THNR","HMYY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995931","title":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995931","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995931?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392570,"startTime":"0","endTime":"0","summary":"Earnings Flash (HIMS) Hims & Hers Health Posts Q2 Loss $0.37, vs. FactSet Est of $0.05 Loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HEAL","HIMS","THNR","HMYY","HIYY","HIMY","HIMZ","GLAM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995959","title":"Hims & Hers Q2 FY26 Net Loss Widens to $86.3 Million; Revenue Rises 38% to $753.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995959","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658995959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:09","pubTimestamp":1786392559,"startTime":"0","endTime":"0","summary":"Hims & Hers Q2 FY26 net loss widens to $86.3 million; revenue rises 38% to $753.2 millionHims & Hers posted Q2 2026 revenue of USD 753.2 million, up 38% year-over-year; net results swung to a USD 86.3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL2PdtJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMZ","HMYY","HIYY","HIMS","HIMY","BK4196","THNR","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959334","title":"Hims & Hers Health Inc: Making a Multi-Year Commitment to Invest in AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959334?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","GLAM","HEAL","HIYY","HIMS","HIMZ","THNR","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695934","title":"Hims & Hers Health Inc: Expect AI Investment to Pay for Itself Within 12 to 18 Months, Expect it to Make Offerings More Affordable for Customers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695934?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392524,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4471PK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIYY","HIMY","THNR","BK4196","HMYY","HIMZ","HEAL","GLAM","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959350","title":"Hims & Hers Posts Higher Quarterly Revenue on Strong Subscriber Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959350","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959350?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392494,"startTime":"0","endTime":"0","summary":"Hims & Hers posts higher quarterly revenue on strong subscriber growthNEW YORK, Aug 10 -Hims & Hers HealthHIMS.Non Monday posted a rise in second-quarter revenue as the telehealth company benefited from an increase in subscribers and expanding its personalized healthcare offerings.The company reported revenue of $753 million during the quarter, compared with $544 million a year ago. Analysts were expecting a revenue of $699.89 million, per data compiled by LSEG.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4471ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIMY","HMYY","BK4196","HEAL","GLAM","HIMS","THNR","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959874","title":"Hims & Hers Health Q2 EPS $(0.37) Misses Estimate, Sales $753.214M Beat $699.889M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959874","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959874?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392452,"startTime":"0","endTime":"0","summary":"Hims &amp; Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over earnings of $0.17 per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61091412/hims-hers-health-q2-eps-0-37-misses-0-03-estimate-sales-753-214m-beat-699-889m-estimate","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimat...","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HEAL","GLAM","HIMZ","THNR","HIYY","HIMY","HMYY","BK4196"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2658598159","title":"Hims & Hers Health Shares Rise in Extended Trade Following Results, Last up 3% at $33","url":"https://stock-news.laohu8.com/highlight/detail?id=2658598159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658598159?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:07","pubTimestamp":1786392428,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL6N4470Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HMYY","HEAL","BK4196","HIMY","HIYY","HIMZ","THNR","HIMS","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959895","title":"Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959895","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959895?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:06","pubTimestamp":1786392361,"startTime":"0","endTime":"0","summary":"BRIEF-Hims & Hers Health Q2 Revenue USD 753 Million Vs. IBES Estimate USD 699.9 MillionAug 10  - Hims & Hers Health Q2 net income USD -86.3 million.outlook FY revenue USD 3,100-3,300 million vs. IBES estimate USD 2,928 millionoutlook FY adjusted EBITDA USD 275-325 million vs. IBES estimate USD 296.2 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HIMZ","GLAM","HIMY","HIMS","HEAL","HMYY","BK4196","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959814","title":"Hims & Hers Health Q2 EPS USD -0.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959814?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIYY","HEAL","HIMY","HIMZ","HMYY","GLAM","HIMS","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959546","title":"Hims & Hers Health, Inc. Q3 REV View $793.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959546?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMS","GLAM","HIMZ","BK4196","HEAL","HMYY","THNR","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658956027","title":"Hims & Hers Health: Building Increased Conviction in Our 2030 Targets of at Least $6.5 Bln in Revenue and $1.3 Bln in Adj Ebitda","url":"https://stock-news.laohu8.com/highlight/detail?id=2658956027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658956027?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXTNRWFK:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIMY","HIMS","BK4196","HIMZ","HIYY","THNR","GLAM","HEAL","HMYY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}